Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Reported Sunday, Amarin Presents Mechanistic Insights Into EPA's Cardiovascular Protection Through Lipoprotein(a) Oxidation Inhibition And NLRP3 Inflammasome Pathway Modulation

Author: Benzinga Newsdesk | September 02, 2025 03:42am

Posted In: AMRN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist